Studies

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care

Full text | Download pdf

Sofia Shrestha, PharmD, CSP, Fairview Home Infusion; Dana Simonson, PharmD, BCPS, Fairview Pharmacy Services; Alicia Zagel, PhD, MPH, Fairview Pharmacy Services

Measure the incidence and severity of infusion-related reactions in patients receiving ocrelizumab administered in both hospital-based and outpatient sites of care.

Read More »

Patient-Reported Outcomes for Understanding of Instructions and Success Rates in the 65+ Age Group Receiving Home-Based Outpatient Parenteral Antimicrobial Therapy (OPAT)

Full text | Download pdf

Danell Haines, PhD, Research Consultant; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA

Patients in the 65+ age group and those receiving outpatient parenteral antimicrobial therapy (OPAT) in the home setting are increasing. There is a void in research that investigates

Read More »
Infusion Journal is generously Supported by:
Baxter